Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
| Revenue (Most Recent Fiscal Year) | $1.22B |
| Net Income (Most Recent Fiscal Year) | $181.86M |
| PE Ratio (Current Year Earnings Estimate) | 41.11 |
| PE Ratio (Trailing 12 Months) | 42.06 |
| PEG Ratio (Long Term Growth Estimate) | 8.62 |
| Price to Sales Ratio (Trailing 12 Months) | 9.34 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 5.37 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 30.82 |
| Pre-Tax Margin (Trailing 12 Months) | 19.81% |
| Net Margin (Trailing 12 Months) | 14.97% |
| Return on Equity (Trailing 12 Months) | 13.23% |
| Return on Assets (Trailing 12 Months) | 10.61% |
| Current Ratio (Most Recent Fiscal Quarter) | 4.55 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.35 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.09 |
| Inventory Turnover (Trailing 12 Months) | 2.07 |
| Book Value per Share (Most Recent Fiscal Quarter) | $13.47 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.49 |
| Earnings per Share (Most Recent Fiscal Year) | $1.72 |
| Diluted Earnings per Share (Trailing 12 Months) | $1.15 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 156.82M |
| Free Float | 154.78M |
| Market Capitalization | $11.35B |
| Average Volume (Last 20 Days) | 2.65M |
| Beta (Past 60 Months) | 1.28 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.30% |
| Percentage Held By Institutions (Latest 13F Reports) | 98.95% |
| Annual Dividend (Based on Last Quarter) | $0.32 |
| Dividend Yield (Based on Last Quarter) | 0.44% |